Carleen Klumpp‐Thomas
National Institutes of Health(US)Innovative Clinical Research(US)National Center for Advancing Translational Sciences(US)
Publications by Year
Research Areas
Computational Drug Discovery Methods, Ubiquitin and proteasome pathways, Cancer, Hypoxia, and Metabolism, Bioinformatics and Genomic Networks, Genetics, Bioinformatics, and Biomedical Research
Most-Cited Works
- → Therapeutic strategies for diffuse midline glioma from high-throughput combination drug screening(2019)251 cited
- → Identification of SARS-CoV-2 3CL Protease Inhibitors by a Quantitative High-Throughput Screening(2020)222 cited
- → Serologic Cross-Reactivity of SARS-CoV-2 with Endemic and Seasonal Betacoronaviruses(2021)189 cited
- → Therapeutic targeting of ATR yields durable regressions in small cell lung cancers with high replication stress(2021)176 cited
- → Standardization of ELISA protocols for serosurveys of the SARS-CoV-2 pandemic using clinical and at-home blood sampling(2021)162 cited
- → Undiagnosed SARS-CoV-2 seropositivity during the first 6 months of the COVID-19 pandemic in the United States(2021)138 cited